Cas:101696-41-7 9-O-(1,2:5,6-Di-O-isopropylidene-alpha-D-glucofuranosyl)-9-boratabicyclo[3.3.1]nonane potassium salt manufacturer & supplier

Chemical Name:9-O-(1,2:5,6-Di-O-isopropylidene-alpha-D-glucofuranosyl)-9-boratabicyclo[3.3.1]nonane potassium salt

CAS.NO:101696-41-7

Synonyms:9-O-(1,2:5,6-Di-O-isopropylidene-alpha-D-glucofuranosyl)-9-boratabicyclo[3.3.1]nonane potassium salt;9-O-(1,2:5,6-Di-O-isopropylidene-a-D-glucofuranosyl)-9-boratabicyclo[3.3.1]nonane, Potassium Salt

Molecular Formula:C₂₀H₃₄BO_6.K

Molecular Weight:420.39

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 9-O-(1,2:5,6-Di-O-isopropylidene-alpha-D-glucofuranosyl)-9-boratabicyclo[3.3.1]nonane potassium salt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,9-O-(1,2:5,6-Di-O-isopropylidene-a-D-glucofuranosyl)-9-boratabicyclo[3.3.1]nonane, Potassium Salt physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,9-O-(1,2:5,6-Di-O-isopropylidene-a-D-glucofuranosyl)-9-boratabicyclo[3.3.1]nonane, Potassium Salt Use and application,9-O-(1,2:5,6-Di-O-isopropylidene-a-D-glucofuranosyl)-9-boratabicyclo[3.3.1]nonane, Potassium Salt technical grade,usp/ep/jp grade.

Related News: Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder. 6-(5-acetyl-7-methylcoumarinyl)oxyacetic acid manufacturers Biogen’s Alzheimer’s drug, Aduhelm, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug. 1-((2R,4S,5R)-4-(p-tolyloxy)-5-((p-tolyloxy)methyl)tetrahydrofuran-2-yl)-5-(trimethylsilyl)pyrimidine-2,4(1H,3H)-dione suppliers “In the past few years, the pharmaceutical industry has seen rapid growth driven by the growth of small molecules’ innovations, complex APIs and the increasing need to optimize available resources. 2,3-O-Isopropyliden-N,N-dimethyl-α-D-lyxofuranuronamid vendor & factory Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder. ,Biogen’s Alzheimer’s drug, Aduhelm, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug.